Nyxoah S.A. (id:391 NYXH)
8.10 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 5:34:47 PM)
Exchange closed, opens in 15 hours 25 minutes
3.85 EUR (3.85%)
3.32 EUR (3.32%)
3.00 EUR (3.00%)
23.48 EUR (23.48%)
80.00 EUR (80.00%)
-59.50 EUR (-59.50%)
About Nyxoah S.A.
Market Capitalization 287.44M
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
| Headquarters (address) |
Rue Edouard Belin 12 Mont-Saint-Guibert 1435 Belgium |
| Phone | 32 10 22 23 55 |
| Website | https://www.nyxoah.com |
| Employees | 146 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Ticker | NYXH |
| Exchange | European Stock Exchange |
| Currency | EUR |
| 52 week range | 3.79 - 17.60 |
| Market Capitalization | 287.44M |
| P/E trailing | -5.05 |
| P/E forward | -4.44 |
| Price/Sale | 56.56 |
| Price/Book | 2.52 |
| Beta | 3.00 |
| EPS | -1.72 |
| EPS Belgium (ID:14, base:79) | 4.60 |